These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18455783)

  • 1. Bioavailability of (+)-methamphetamine in the pigeon following an intramuscular dose.
    Hendrickson HP; Hardwick WC; McMillan DE; Owens SM
    Pharmacol Biochem Behav; 2008 Sep; 90(3):382-6. PubMed ID: 18455783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of methamphetamine and its metabolite amphetamine in brain and other tissues in rats after intravenous administration.
    Rivière GJ; Gentry WB; Owens SM
    J Pharmacol Exp Ther; 2000 Mar; 292(3):1042-7. PubMed ID: 10688621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestation time-dependent pharmacokinetics of intravenous (+)-methamphetamine in rats.
    White S; Laurenzana E; Hendrickson H; Gentry WB; Owens SM
    Drug Metab Dispos; 2011 Sep; 39(9):1718-26. PubMed ID: 21632964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous locomotor activity and pharmacokinetics of intravenous methamphetamine and its metabolite amphetamine in the rat.
    Rivière GJ; Byrnes KA; Gentry WB; Owens SM
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1220-6. PubMed ID: 10565845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex- and dose-dependency in the pharmacokinetics and pharmacodynamics of (+)-methamphetamine and its metabolite (+)-amphetamine in rats.
    Milesi-Hallé A; Hendrickson HP; Laurenzana EM; Gentry WB; Owens SM
    Toxicol Appl Pharmacol; 2005 Dec; 209(3):203-13. PubMed ID: 15916788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (+)-Methamphetamine-induced spontaneous behavior in rats depends on route of (+)METH administration.
    Gentry WB; Ghafoor AU; Wessinger WD; Laurenzana EM; Hendrickson HP; Owens SM
    Pharmacol Biochem Behav; 2004 Dec; 79(4):751-60. PubMed ID: 15582684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics of methamphetamine self-administration in male and female rats.
    Milesi-Hallé A; Hambuchen MD; McMillan DE; Michael Owens S
    Drug Alcohol Depend; 2015 May; 150():164-9. PubMed ID: 25796510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with a monoclonal antibody against methamphetamine and amphetamine reduces maternal and fetal rat brain concentrations in late pregnancy.
    White SJ; Hendrickson HP; Atchley WT; Laurenzana EM; Gentry WB; Williams DK; Owens SM
    Drug Metab Dispos; 2014 Aug; 42(8):1285-91. PubMed ID: 24839971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of anti-(+)-methamphetamine monoclonal antibody to significantly alter (+)-methamphetamine and (+)-amphetamine disposition in rats.
    Laurenzana EM; Byrnes-Blake KA; Milesi-Hallé A; Gentry WB; Williams DK; Owens SM
    Drug Metab Dispos; 2003 Nov; 31(11):1320-6. PubMed ID: 14570763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative pharmacokinetics of florfenicol in the chicken, pigeon and quail.
    Ismail M; El-Kattan YA
    Br Poult Sci; 2009 Jan; 50(1):144-9. PubMed ID: 19234939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers.
    Schepers RJ; Oyler JM; Joseph RE; Cone EJ; Moolchan ET; Huestis MA
    Clin Chem; 2003 Jan; 49(1):121-32. PubMed ID: 12507968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological effects of two anti-methamphetamine monoclonal antibodies. Supporting data for lead candidate selection for clinical development.
    Laurenzana EM; Stevens MW; Frank JC; Hambuchen MD; Hendrickson HP; White SJ; Williams DK; Owens SM; Gentry WB
    Hum Vaccin Immunother; 2014; 10(9):2638-47. PubMed ID: 25483484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human methamphetamine pharmacokinetics simulated in the rat: single daily intravenous administration reveals elements of sensitization and tolerance.
    Segal DS; Kuczenski R
    Neuropsychopharmacology; 2006 May; 31(5):941-55. PubMed ID: 16123749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human pharmacology of the methamphetamine stereoisomers.
    Mendelson J; Uemura N; Harris D; Nath RP; Fernandez E; Jacob P; Everhart ET; Jones RT
    Clin Pharmacol Ther; 2006 Oct; 80(4):403-20. PubMed ID: 17015058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a liquid chromatography-tandem mass spectrometric method for the determination of methamphetamine and amphetamine using small volumes of rat serum.
    Hendrickson HP; Milesi-Hallé A; Laurenzana EM; Owens SM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jul; 806(2):81-7. PubMed ID: 15171915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse.
    Cho AK; Melega WP; Kuczenski R; Segal DS
    Synapse; 2001 Feb; 39(2):161-6. PubMed ID: 11180503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in methamphetamine pharmacokinetics in adult rats and its transfer to pups through the placental membrane and breast milk.
    Rambousek L; Kacer P; Syslova K; Bumba J; Bubenikova-Valesova V; Slamberova R
    Drug Alcohol Depend; 2014 Jun; 139():138-44. PubMed ID: 24726427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escalating dose pretreatment induces pharmacodynamic and not pharmacokinetic tolerance to a subsequent high-dose methamphetamine binge.
    O'Neil ML; Kuczenski R; Segal DS; Cho AK; Lacan G; Melega WP
    Synapse; 2006 Nov; 60(6):465-73. PubMed ID: 16897726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative single-dose pharmacokinetics of clonazepam following intravenous, intramuscular and oral administration to healthy volunteers.
    Crevoisier C; Delisle MC; Joseph I; Foletti G
    Eur Neurol; 2003; 49(3):173-7. PubMed ID: 12646763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and tolerability of intramuscular, oral and intravenous aripiprazole in healthy subjects and in patients with schizophrenia.
    Boulton DW; Kollia G; Mallikaarjun S; Komoroski B; Sharma A; Kovalick LJ; Reeves RA
    Clin Pharmacokinet; 2008; 47(7):475-85. PubMed ID: 18563956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.